Power Law company profile

Vividion Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2014 Unicorn

Expanding the therapeutic potential of small molecules

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

24 investors on Vividion Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

ARCH Venture Partners

Versant Ventures

Cardinal Partners

Series B+ 21 investors entered at this stage

Tavistock Group

Avoro Capital Advisors

SoftBank

Driehaus Capital Management

T. Rowe Price

Bristol-Myers Squibb

Boxer Capital

Citadel

Trinitas Capital

BVF Partners

Woodline Partners

Logos Capital

BlackRock

Mubadala Capital

Celgene

Acuta Capital Partners

Nextech Invest

Casdin Capital

Altitude Life Science Ventures

RA Capital Management

Scripps Translational Science Institute

Global footprint

Where Vividion Therapeutics has talent and traffic

AI talent share

0.8% of workforce is AI talent
(2 of 263 staff)

Core AI10.38%

Other AI10.38%

Non-AI workforce26199.24%

Workforce by country

3 countries with
team presence

🇺🇸 United States98.3%

🇩🇪 Germany1.3%

🇨🇦 Canada0.4%

3 countries shown

Web traffic by country

8.1K monthly visits
across markets

🇺🇸 United States80.2%

🇮🇳 India14.8%

🇯🇵 Japan6.2%

Top 3 markets shown

Patent intelligence

$1M patent portfolio · 19 active families

Estimated portfolio value

$1M

0.07% of valuation · 24.1× smaller than top peer Kymera Therapeutics ($26M)

19 active patent families

Where Vividion Therapeutics innovates BiochemistryMolecular biologyCarcinosisCancer researchCell biology

Where Vividion Therapeutics concentrates vs peers

Each axis is a top-10 topic across Vividion Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Vividion Therapeutics

An AI-synthesized read of the highest-engagement posts about Vividion Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vividion Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles